Last Updated: November 16, 2026

Litigation Details for CELGENE CORPORATION v. APOTEX INC. (D.N.J. 2019)

« Back to Dashboard


CELGENE CORPORATION v. APOTEX INC. (D.N.J. 2019)

Docket ⤷  Start Trial Date Filed 2019-06-19
Court District Court, D. New Jersey Date Terminated 2021-03-10
Cause 15:1126 Patent Infringement Assigned To Susan Davis Wigenton
Jury Demand None Referred To Leda Dunn Wettre
Parties CELGENE CORPORATION
Patents 6,315,720; 6,561,977; 6,755,784; 7,189,740; 7,465,800; 7,468,363; 7,855,217; 8,315,886; 8,404,717; 8,626,531; 8,741,929; 9,056,120
Attorneys CHARLES MICHAEL LIZZA
Firms Quinn Emanuel Uquhart & Sullival LLP
Link to Docket External link to docket
Small Molecule Drugs cited in CELGENE CORPORATION v. APOTEX INC.
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Details for CELGENE CORPORATION v. APOTEX INC. (D.N.J. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-06-19 External link to document
2019-06-19 1 Complaint alleging that the claims of U.S. Patents No. 6,315,720 (“the ’720 patent”), 6,561,977 (“the …219 patent”), and 8,431,598 (the “’598 patent”), all owned by Celgene (collectively, “the patents-in-…PageID: 7 ’977 patent”), 6,755,784 (“the ’784 patent”), 8,315,886 (“the ’886 patent”), 8,626,531 (“the…“the ’531 patent”), 7,465,800 (“the ’800 patent”), 7,855,217 (“the ’217 patent”), 7,468,363 (“the ’363…claims of U.S. Patents No. 7,189,740 (“the ’740 patent”), 8,404,717 (“the ’717 patent”), and 9,056,120 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.